Clinical TrialDepressive DisordersRecruiting

Veterans' Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-Life (KAP)

This observational cohort study (n=30) will explore how veterans aged 65 and older enrolled in VA healthcare perceive ketamine-assisted psychotherapy (KAP) for depression and end-of-life distress.

Target Enrollment
30 participants
Study Type
Phase NA observational
Design
Non-randomized

Detailed Description

This mixed-methods, cross-sectional cohort study uses interviews and questionnaires to examine how veterans aged 65+ enrolled in VA care understand ketamine-assisted psychotherapy for depression and end-of-life distress.

Participants complete brief demographics, PHQ-9, the Ten-Item Personality Inventory, and the Death Anxiety Questionnaire, then take part in a recorded story-completion interview; transcripts will be thematically coded and analysed for prevalence and correlates with symptom measures.

Study Protocol

Preparation

sessions

Dosing

sessions

Integration

sessions

Therapeutic Protocol

Manualized psychotherapy included

Participants

Ages
65 – 99
Sexes
Male & Female

Inclusion Criteria

  • Inclusion Criteria:
  • Veterans enrolled in VA care.
  • Age 65 or older.
  • Fluent in written and spoken English.

Exclusion Criteria

  • Exclusion Criteria:
  • Cognitively impaired to the extent that patient cannot comprehend the survey.

Study Details

  • Status
    Recruiting
  • Phase
    Phase NA
  • Type
    observational
  • Design
    Non-randomized
  • Target Enrollment30 participants
  • Timeline
    Start: 2024-11-08
    End: 2025-04-01
  • Topic
    Depressive Disorders

Locations

Stratton VA Medical Center — Albany, New York, United States

Your Library